# Eledon Pharmaceuticals, Inc.: Form 8-K, filed Jul 12, 2024

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2024-07-12
- Accepted by EDGAR: Jul 12, 2024, 16:30 ET
- Period: 2024-07-10
- Accession: 0000950170-24-083220
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/eldn-20240710.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000095017024083220/eldn-20240710.htm

Filed Jul 12, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-083220. Last ingested by Listed: Oct 30, 2026, 11:26 ET. No prices; not investment advice.
